Aurinia Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aurinia Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 31% to $175,513,000. The net income raised on -$78,020,000 and profit margin reached -44%. Total operating expenses were $253,056,000.
Profit Margin
| 2014 | 278K | -16.64M | -5988.13% |
|---|---|---|---|
| 2015 | 235K | -18.60M | -7917.87% |
| 2016 | 173K | -23.29M | -13465.32% |
| 2017 | 420K | -70.79M | -16855.24% |
| 2018 | 463K | -64.12M | -13848.81% |
| 2019 | 318K | -123.84M | -38945.28% |
| 2020 | 50.11M | -102.68M | -204.88% |
| 2021 | 45.60M | -180.96M | -396.81% |
| 2022 | 134.03M | -108.18M | -80.71% |
| 2023 | 175.51M | -78.02M | -44.45% |
AUPH Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 175.51M | 134.03M | 45.60M | 50.11M | 318K | 463K | 420K | 173K | 235K | 278K |
Cost of revenue | 14.14M | 5.66M | 1.09M | 50.32M | 52.86M | 41.38M | 1K | 4K | 12K | 37K |
Gross profit | 161.36M | 128.36M | 44.51M | -209K | -52.54M | -40.91M | 419K | 169K | 223K | 241K |
Operating exp. | ||||||||||
Research and development | 49.64M | 44.98M | 51.13M | 50.32M | 52.86M | 41.38M | 33.93M | 14.53M | 15.98M | 9.11M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 253.05M | 239.83M | 225.24M | 147.59M | 76.56M | 56.62M | 47.48M | 22.98M | 23.80M | 17.52M |
Operating income | -91.69M | -111.47M | -180.73M | -104.29M | -82.53M | -56.15M | -47.06M | -22.81M | -23.58M | -17.28M |
Other income (expenses), net | 14.22M | 5.11M | 529K | 1.51M | -41.16M | -7.88M | -23.72M | -508K | 4.97M | -2.13M |
Income before tax | -77.46M | -106.35M | -180.20M | -102.77M | -123.70M | -64.04M | -70.79M | -23.29M | -18.60M | -16.64M |
Income tax expense | 551K | 1.82M | 760K | -94K | 144K | 73K | 23.92M | 481K | -4.97M | 30K |
Net income | -78.02M | -108.18M | -180.96M | -102.68M | -123.84M | -64.12M | -70.79M | -23.29M | -18.60M | -16.64M |
Earnings per share | ||||||||||
Basic EPS | -0.54 | -0.76 | -1.4 | -0.87 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 |
Diluted EPS | -0.54 | -0.76 | -1.4 | -0.87 | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 | -0.57 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |